Impact of Bariatric Surgery on Comorbidities

https://doi.org/10.1016/j.suc.2011.08.003Get rights and content

Section snippets

Type 2 diabetes mellitus

The prevalence of type 2 diabetes mellitus (DM) is increasing worldwide and, from an epidemiologic point of view, almost 90% of diabetes cases could be prevented by avoiding obesity.11, 12 The estimated attributable risk of excess body weight leading to development of type 2 DM is extremely high and no other modifiable factor has such an impact on the health of the general population.12 Total costs of diabetes care were estimated to be $132 billion in 2002.13 Most (67%) people with type 2 DM

Hypertension

Hypertension is one of the most common comorbidities associated with obesity. About 40% to 70% of patients undergoing BS are hypertensive.7, 54 Mechanisms proposed to explain the contribution of obesity to the development of hypertension include an altered renin-angiotensin-aldosterone system, increased intra-abdominal pressure,55 increased sympathetic nervous system activity, development of insulin resistance, hyperleptinemia, leptin resistance, altered coagulation factors, as well as

Hyperlipidemia

Hyperlipidemia is present in up to 50% of morbidly obese patients and is a major modifiable risk factor in development of atherosclerosis and CAD.71 Hyerlipidemia refers to high levels of low-density lipoprotein (LDL), triglycerides (TG), and/or total cholesterol, as well as low high-density lipoprotein (HDL). BS greatly improves secondary hypercholesterolemia and mixed forms of hyperlipidemia. There is a relationship among measures of central obesity, insulin resistance, and impaired glucose

Congestive Heart Failure

The combination of increased adipose cells and increased lean muscle mass in obese patients results in high cardiac output and an increased circulating volume. Weight loss caused by caloric restriction or surgery promotes favorable hemodynamic changes referred to as reverse remodeling. Regression of left ventricle (LV) mass and chamber size has been shown universally.81

BS in morbidly obese patients decreases the thickness of the LV wall and the overall ventricular mass,82, 83 promotes both

Obstructive sleep apnea and asthma

Obstructive sleep apnea (OSA) is a common problem among obese patients,7 with a prevalence rate as high as 77%.98 Neck circumference more than 17 inches in men and 16 inches in women is a good predictor of OSA.99 Some studies suggest that, despite availability of prediction models, the diagnosis of OSA cannot be made easily98, 100 without routine polysomnography testing for all patients considering BS.98 Chronic obstructive pulmonary disease (COPD) and other pulmonary disorders (including OSA)

Renal disorders

The pathophysiology underlying obesity-associated renal disorders includes insulin resistance, adiponectin deficiency, hyperaldosteronism, and many other pathogenetic factors.107 The abnormalities of renal structure in obese and morbidly obese individuals include increased kidney weight, glomerulomegaly, disorder of podocytes, mesangial expansion, and abnormalities of the renal interstitium. These abnormalities are accompanied by functional abnormalities like renal hyperperfusion, increased

Digestive disorders

Obese patients have up to 2.4 times more gastroesophageal symptoms compared with nonobese patients.123 They also have higher distal esophageal acid exposure124 and a higher number of gastroesophageal reflux episodes.125 Cremieux and colleagues10 found a significant decrease (39.4% before surgery vs 13.5% after BS) in medication use for gastroenterologic disorders after BS.

As expected, different BS procedures have varying effects on gastroesophageal reflux disease (GERD). A recent meta-analysis

Musculoskeletal disorders

Obesity is associated with a range of mobility problems, musculoskeletal pains, osteoarthritis and gout, all of which significantly affect quality of life.135 For every 2-unit increase (5 kg) in BMI, there is a 36% increase in the risk of developing painful joint conditions such as osteoarthritis.136 Disease of the musculoskeletal and connective system, such as arthropathies, osteoporosis, and rheumatism, decreased significantly after BS.10, 16, 63 There is also sustained improvement in

Psychological, neurologic, and sexual disorders

Psychological factors are intimately connected with morbid obesity and food may be used to satisfy certain cravings. Weight loss greatly improves depression caused by obesity.76, 139 A Greek study140 surveying 59 obese women before and after bariatric procedures found significant reductions in depression (P<.001) and sexual pain levels (P = .014) as well as significant improvements in sexual desire, arousal (P = .001), lubrication (P = .003), satisfaction (P = .012), and total sexual function (P

Cancer

In the United States, approximately 85,000 new cancer cases per year are related to obesity. Recent research has found that, when the BMI increases by 5 kg/m2, cancer mortality increases by 10%.146 The cancer-protective role of metabolic surgery is strongest for obesity-related tumors in women; however, the underlying mechanisms may involve both weight-dependent and weight-independent effects. These effects include the improvement of insulin resistance with attenuation of the metabolic syndrome

Summary

Published data show that BS not only leads to significant and sustained weight loss but also resolves or improves multiple comorbidities associated with morbid obesity. Evidence suggests that the earlier the intervention the better the resolution of comorbidities. Patients with metabolic syndrome and comorbidities associated with morbid obesity should be promptly referred for consideration for BS earlier in the disease process.

First page preview

First page preview
Click to open first page preview

References (149)

  • K.J. MacDonald et al.

    The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus

    J Gastrointest Surg

    (1997)
  • D. Flum et al.

    Impact of gastric bypass operation on survival: a population-based analysis

    J Am Coll Surg

    (2004)
  • P. Abellán et al.

    Severe hypoglycemia after gastric bypass surgery for morbid obesity

    Diabetes Res Clin Pract

    (2008)
  • M. Hinojosa et al.

    Resolution of systemic hypertension after laparoscopic gastric bypass

    J Gastrointest Surg

    (2009)
  • J.E. Varela et al.

    Correlations between intra-abdominal pressure and obesity-related co-morbidities

    Surg Obes Relat Dis

    (2009)
  • S.E. Dunkle-Blatter et al.

    Outcomes among elderly bariatric patients at a high-volume center

    Surg Obes Relat Dis

    (2007)
  • A. Carlin et al.

    Vitamin D depletion impairs hypertension resolution after Roux-en-Y gastric bypass

    Am J Surg

    (2008)
  • J.A. Vogel et al.

    Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery

    Am J Cardiol

    (2007)
  • S.A. Cunneen

    Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding

    Surg Obes Relat Dis

    (2008)
  • S. Rossner et al.

    Early and late effects of weight loss on lipoprotein metabolism in severe obesity

    Atherosclerosis

    (1987)
  • R.R. Jhaveri et al.

    Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery

    Surg Obes Relat Dis

    (2009)
  • C.A. Garza et al.

    Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity

    Am J Cardiol

    (2010)
  • M.F. Algahim et al.

    Progressive regression of left ventricular hypertrophy two years after bariatric surgery

    Am J Med

    (2010)
  • C. McCloskey et al.

    Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy

    Surg Obes Relat Dis

    (2007)
  • P. Habib et al.

    Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis

    Am J Cardiol

    (2009)
  • P.W. Olejniczak et al.

    Sleep disorders

    Med Clin North Am

    (2003)
  • L. Busetto et al.

    Variation in lipid levels in morbidly obese patients operated with the LAP-BAND adjustable gastric banding system: effects of different levels of weight loss

    Obes Surg

    (2000)
  • H.W. Kuhlmann et al.

    Cost-effective bariatric surgery in Germany today

    Obes Surg

    (2000)
  • M.A. Maggard et al.

    Meta-analysis: surgical treatment of obesity

    Ann Intern Med

    (2005)
  • L. Sjostrom et al.

    Effects of bariatric surgery on mortality in Swedish obese subjects

    N Engl J Med

    (2007)
  • H. Buchwald et al.

    Trends in mortality in bariatric surgery: a systematic review and meta-analysis

    Surgery

    (2007)
  • J.B. Dimick et al.

    Surgical mortality as an indicator of hospital quality: the problem with small sample size

    JAMA

    (2004)
  • N.V. Christou et al.

    Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients

    Ann Surg

    (2004)
  • P.Y. Cremieux et al.

    The impact of bariatric surgery on comorbidities and medication use among obese patients

    Obes Surg

    (2010)
  • A.H. Mokdad et al.

    The continuing epidemics of obesity and diabetes in the United States

    JAMA

    (2001)
  • P. Hogan et al.

    Economic costs of diabetes in the US in 2002

    Diabetes Care

    (2003)
  • T.M. Owens

    Morbid obesity: the disease and comorbidities

    Crit Care Nurs Q

    (2003)
  • L. Sjostrom et al.

    Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

    N Engl J Med

    (2004)
  • J.B. Dixon et al.

    Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

    JAMA

    (2008)
  • J. Picot et al.

    The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation

    Health Technol Assess

    (2009)
  • W. Pories et al.

    Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

    Ann Surg

    (1995)
  • W.J. Pories et al.

    Etiology of type II diabetes mellitus: role of the foregut

    World J Surg

    (2001)
  • S. Moon Han et al.

    Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients

    Obes Surg

    (2005)
  • S. Karamanakos et al.

    Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study

    Ann Surg

    (2008)
  • F. Rodieux et al.

    Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

    Obesity (Silver Spring)

    (2008)
  • E. Bobbioni-Harsch et al.

    Independent evolution of heart autonomic function and insulin sensitivity during weight loss

    Obesity (Silver Spring)

    (2009)
  • B. Woelnerhanssen et al.

    Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial

    Surg Obes Relat Dis

    (2011)
  • M. Bose et al.

    Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery

    J Diabetes

    (2010)
  • G.H. Ballantyne et al.

    The surgical treatment of type II diabetes mellitus: changes in HOMA insulin resistance in the first year following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB)

    Obes Surg

    (2009)
  • F. Abbatini et al.

    Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes

    Surg Endosc

    (2010)
  • Cited by (40)

    • Percutaneous Electrical Neurostimulation of Dermatome T6 to Reduce Appetite

      2017, Metabolism and Pathophysiology of Bariatric Surgery: Nutrition, Procedures, Outcomes and Adverse Effects
    • Management of obesity in patients with type 2 diabetes mellitus in primary care

      2016, Diabetes and Metabolic Syndrome: Clinical Research and Reviews
      Citation Excerpt :

      Table 21 tries to illustrate the impact of BS on comorbidities. Apart from above BS has been associated with both prevention and improvement/resolution of obesity associated renal dysfunction, improvement in joint pains, arthralgia and osteoarthritis and significant improvement in psychological, Neurological and Sexual disorders [79]. Table 22 compares the recommendations of different guidelines for the position of BS in obesity treatment.

    View all citing articles on Scopus

    The authors gratefully acknowledge the help of Mr Donald A. Risucci PhD in editing this manuscript.

    View full text